Weighted Average Number of Shares Outstanding, Basic of MAXCYTE, INC. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Maxcyte, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2019 to Q3 2025.
  • Maxcyte, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 107M shares, a 1.43% increase year-over-year.
  • Maxcyte, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 105M shares, a 1.53% increase from 2023.
  • Maxcyte, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 103M shares, a 1.54% increase from 2022.
  • Maxcyte, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 102M shares, a 12.2% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

MAXCYTE, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 107M +1.5M +1.43% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 106M +1.76M +1.69% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 106M +1.86M +1.79% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 105M +1.58M +1.53% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 105M +1.66M +1.61% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 105M +1.58M +1.53% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 104M +1.24M +1.21% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 103M +1.57M +1.54% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 103M +1.64M +1.61% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 103M +1.64M +1.61% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 103M +1.54M +1.52% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 102M +11.1M +12.2% 01 Oct 2022 31 Dec 2022 10-K 12 Mar 2024
Q3 2022 102M +6.14M +6.42% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 101M +16.7M +19.7% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 101M +20.3M +25.1% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 90.6M 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2023
Q3 2021 95.7M +18.6M +24.1% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 84.7M +18.9M +28.7% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 81M 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q3 2020 77.1M 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 65.8M 01 Apr 2020 30 Jun 2020 10-Q 13 Sep 2021

MAXCYTE, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 105M +1.58M +1.53% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 103M +1.57M +1.54% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 102M +11.1M +12.2% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024
2021 90.6M +21.2M +30.5% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023
2020 69.5M +13.1M +23.2% 01 Jan 2020 31 Dec 2020 10-K 22 Mar 2022
2019 56.4M 01 Jan 2019 31 Dec 2019 10-K 22 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.